Epidermal growth factor receptor serum (sEGFR) level may predict response in patients with EGFR-positive advanced colorectal cancer treated with gefitinib?

Source:http://linkedlifedata.com/resource/pubmed/id/18327586

Download in:

View as

General Info

PMID
18327586